Biocept, Inc. (BIOCQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Dec 19, 2024, 4:00 PM EST
Biocept Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
Cash & Equivalents | 6.63 | 12.9 | 28.86 | 14.37 | 9.3 | 3.42 | Upgrade
|
Cash & Short-Term Investments | 6.63 | 12.9 | 28.86 | 14.37 | 9.3 | 3.42 | Upgrade
|
Cash Growth | -71.07% | -55.32% | 100.89% | 54.47% | 171.70% | 59.48% | Upgrade
|
Receivables | 0.8 | 2.15 | 13.79 | 14.15 | 3.53 | 1.57 | Upgrade
|
Inventory | 0.55 | 0.76 | 2.65 | 1.93 | 0.77 | 0.59 | Upgrade
|
Prepaid Expenses | 0.88 | 0.54 | 0.39 | 2.15 | 0.3 | 0.43 | Upgrade
|
Total Current Assets | 8.86 | 16.34 | 45.69 | 32.6 | 13.89 | 6.01 | Upgrade
|
Property, Plant & Equipment | 12.86 | 14.14 | 14.27 | 14.43 | 3.84 | 2.74 | Upgrade
|
Other Long-Term Assets | 0.39 | 0.39 | 0.46 | 0.43 | - | - | Upgrade
|
Total Assets | 22.1 | 30.87 | 60.42 | 47.45 | 17.73 | 8.75 | Upgrade
|
Accounts Payable | 1.47 | 1.52 | 7.25 | 8.37 | 2.01 | 2.04 | Upgrade
|
Accrued Expenses | 1.53 | 2.25 | 3.02 | 3.17 | 1.98 | 1.77 | Upgrade
|
Short-Term Debt | 0.53 | 0.12 | - | - | - | - | Upgrade
|
Current Portion of Leases | 1.38 | 1.62 | 1.51 | 0.96 | 1.57 | 0.64 | Upgrade
|
Other Current Liabilities | - | - | - | - | - | 0.16 | Upgrade
|
Total Current Liabilities | 4.9 | 5.51 | 11.77 | 12.5 | 5.56 | 4.61 | Upgrade
|
Long-Term Leases | 9.69 | 10.38 | 11.16 | 11.27 | 0.97 | 0.99 | Upgrade
|
Other Long-Term Liabilities | 7.23 | 6.13 | - | - | - | 0.11 | Upgrade
|
Total Liabilities | 21.81 | 22.01 | 22.94 | 23.76 | 6.53 | 5.71 | Upgrade
|
Common Stock | - | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 309.5 | 307.3 | 303.83 | 287.22 | 256.92 | 223.5 | Upgrade
|
Retained Earnings | -309.21 | -298.44 | -266.35 | -263.53 | -245.72 | -220.46 | Upgrade
|
Total Common Equity | 0.29 | 8.86 | 37.48 | 23.69 | 11.2 | 3.04 | Upgrade
|
Shareholders' Equity | 0.29 | 8.86 | 37.48 | 23.69 | 11.2 | 3.04 | Upgrade
|
Total Liabilities & Equity | 22.1 | 30.87 | 60.42 | 47.45 | 17.73 | 8.75 | Upgrade
|
Total Debt | 11.59 | 12.11 | 12.67 | 12.23 | 2.54 | 1.63 | Upgrade
|
Net Cash (Debt) | -4.96 | 0.79 | 16.19 | 2.14 | 6.76 | 1.8 | Upgrade
|
Net Cash Growth | - | -95.13% | 656.94% | -68.36% | 276.30% | - | Upgrade
|
Net Cash Per Share | -7.18 | 1.39 | 32.87 | 5.42 | 98.18 | - | Upgrade
|
Filing Date Shares Outstanding | 2.63 | 0.59 | 0.56 | 0.45 | 0.36 | 0.06 | Upgrade
|
Total Common Shares Outstanding | 2.41 | 0.57 | 0.56 | 0.45 | 0.18 | 0.02 | Upgrade
|
Working Capital | 3.96 | 10.84 | 33.92 | 20.1 | 8.33 | 1.4 | Upgrade
|
Book Value Per Share | 0.12 | 15.57 | 66.73 | 53.05 | 61.39 | 197.17 | Upgrade
|
Tangible Book Value | 0.29 | 8.86 | 37.48 | 23.69 | 11.2 | 3.04 | Upgrade
|
Tangible Book Value Per Share | 0.12 | 15.57 | 66.73 | 53.05 | 61.39 | 197.17 | Upgrade
|
Machinery | 7.98 | 7.17 | 6.16 | 5.56 | 4.57 | 4.41 | Upgrade
|
Construction In Progress | 0.04 | 0.04 | 0.25 | 0.76 | 0.63 | 0.12 | Upgrade
|
Leasehold Improvements | 0.7 | 0.69 | 0.63 | 0.57 | 0.57 | 0.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.